Events

Recall of RaySearch RayStation 2.5, 3.0, 3.5, 4.0, 4.5, 4.7, 5.0 and 4.3 (InverseArc 1.0) (Radiation therapy treatment planning system)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Emergo Asia Pacific Pty Ltd T/a Emergo Australia.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2016-RN-01185-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2016-09-09
  • Event Country
    Australia
  • Event Source
    DHTGA
  • Event Source URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2016-RN-01185-1
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Two issues have been identified with the dose calculation when using a region of interest (roi) of type fixation or support with material override within the patient outline (external roi) in raystation 2.5, 3.0, 3.5, 4.0, 4.5, 4.7, 5.0 and 4.3 (inversearc 1.0). these are: - when an roi with material override overlaps a fixation or support roi, the material used for dose calculation in the overlapping region may not be as intended.- when a support or fixation roi overlaps the patient outline (external roi) in a dose grid voxel along the outer surface of the patient outline, the density used for dose calculation in that voxel may not be as intended.These issues have not caused any patient mistreatment or other incidents. however, the user must be aware of this information to avoid incorrect dose calculations during treatment planning.
  • Action
    A correction of these issues will be available in the next version of RayStation, scheduled for market release in December 2016. In the interim, users are advised that not to use ROIs of type Fixation or Support within the patient outline. Always use other ROI types for material override within the External ROI. A small overlap with the External ROI is acceptable if the Fixation or Support ROI is mainly outside the External ROI.

Device

RaySearch RayStation 2.5, 3.0, 3.5, 4.0, 4.5, 4.7, 5.0 and 4.3 (InverseArc 1.0) (Radiation therap...

Manufacturer

Emergo Asia Pacific Pty Ltd T/a Emergo Australia